Van Cleef Asset Management,Inc Abb Vie Inc. Transaction History

Van Cleef Asset Management,Inc

$876 Million
Q3 2024

A detailed history of Van Cleef Asset Management,Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Van Cleef Asset Management,Inc holds 7,705 shares of ABBV stock, worth $1.54 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

7,705

Previous 7,705 -0.0%

Holding current value

$1.54 Million

Previous $1.32 Million 15.14%

% of portfolio

0.17%

Previous 0.17%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $7,991 - $9,105	-50 Reduced 0.64%	7,705 $1.4 Million
Q4 2023 Feb 02, 2024	BUY	$137.6 - $154.97 $13,760 - $15,497	100 Added 1.31%	7,755 $1.2 Million
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $3,339 - $3,866	-25 Reduced 0.33%	7,655 $1.14 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $212,016 - $263,840	-1,600 Reduced 17.24%	7,680 $1.03 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $5,784 - $6,661	-40 Reduced 0.43%	9,280 $1.48 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $27,662 - $33,174	200 Added 2.19%	9,320 $1.51 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $41,605 - $47,718	-310 Reduced 3.29%	9,120 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $27,931 - $35,341	-260 Reduced 2.68%	9,430 $1.28 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $7,980 - $9,058	-75 Reduced 0.77%	9,690 $1.05 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $15,781 - $17,581	-150 Reduced 1.51%	9,765 $1.1 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $20,460 - $22,524	-200 Reduced 1.98%	9,915 $1.07 Million
Q4 2020 Feb 17, 2021	SELL	$80.49 - $108.67 $8,048 - $10,867	-100 Reduced 0.98%	10,115 $1.08 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $90,205 - $105,871	-1,050 Reduced 9.32%	10,215 $895,000
Q2 2020 Aug 17, 2020	BUY	$73.37 - $98.18 $66,033 - $88,362	900 Added 8.68%	11,265 $1.11 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $126,420 - $191,668	-1,960 Reduced 15.9%	10,365 $790,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $14,426 - $18,050	-200 Reduced 1.6%	12,325 $1.09 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $3,274 - $3,937	-52 Reduced 0.41%	12,525 $948,000
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $32,915 - $42,073	501 Added 4.15%	12,577 $915,000
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $27,770 - $32,684	360 Added 3.07%	12,076 $973,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $23,043 - $28,418	296 Added 2.59%	11,716 $1.08 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $54,679 - $60,786	-615 Reduced 5.11%	11,420 $1.08 Million
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $14,364 - $16,996	160 Added 1.35%	12,035 $1.12 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $10,581 - $14,169	-115 Reduced 0.96%	11,875 $1.12 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $11,195 - $12,276	-125 Reduced 1.03%	11,990 $1.16 Million
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $846,232 - $1.08 Million	12,115	12,115 $1.08 Million

Others Institutions Holding ABBV

# of Institutions

3,783

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Cleef Asset Management,Inc, based on Form 13F filings with the SEC.

News

Stay updated on Van Cleef Asset Management,Inc with notifications on news.

Account

Van Cleef Asset Management,Inc Abb Vie Inc. Transaction History